In last trading session, Trxade Health Inc (NASDAQ:MEDS) saw 57630.0 shares changing hands with its beta currently measuring 2.23. Company’s recent per share price level of $18.06 trading at -$0.43 or -2.33% at ring of the bell on the day assigns it a market valuation of $25.46M. That closing price of MEDS’s stock is at a discount of -64.73% from its 52-week high price of $29.75 and is indicating a premium of 86.38% from its 52-week low price of $2.46. Taking a look at company’s average trading volume volume of 108.90K if we extend that period to 3-months.
Trxade Health Inc (NASDAQ:MEDS) trade information
Upright in the red during last session for losing -2.33%, in the last five days MEDS remained trading in the green while hitting it’s week-highest on Tuesday, 07/02/24 when the stock touched $18.06 price level, adding 5.94% to its value on the day. Trxade Health Inc’s shares saw a change of 420.58% in year-to-date performance and have moved 52.41% in past 5-day. Trxade Health Inc (NASDAQ:MEDS) showed a performance of 165.20% in past 30-days.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
MEDS Dividends
Trxade Health Inc is more likely to be releasing its next quarterly report in August and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
